We are live on ! Find out more
CO

Global Cord Blood Corporation
CO

Delisted

CO was delisted on the 23rd of September, 2022.

Back to rankings

35 hedge funds and large institutions have $96.3M invested in Global Cord Blood Corporation in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

3% less capital invested

Capital invested by funds: $99.1M → $96.3M (-$2.76M)

20% less funds holding

Funds holding: 44 → 35 (-9)

25% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 12

82% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 11

Holders
35
Holders Change
-9
Holders Change %
-20.45%
% of All Funds
0.69%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
2
Increased
9
Reduced
12
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$470K
2
Squarepoint
Squarepoint
New York
+$147K
3
AC
Athos Capital
Hong Kong
+$119K
4
BlackRock
BlackRock
New York
+$81K
5
QOP
Quinn Opportunity Partners
Virginia
+$62K

Top Sellers

Rank Fund Capital Flow
1
JCM
Jayhawk Capital Management
Kansas
-$3.71M
2
Norges Bank
Norges Bank
Norway
-$932K
3
Goldman Sachs
Goldman Sachs
New York
-$337K
4
Millennium Management
Millennium Management
New York
-$303K
5
LAM
Lingohr Asset Management
Germany
-$301K
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$22K -$16.2K -3,392 -43%
UBS Group
27
UBS Group
Switzerland
$11K -$5.64K -1,182 -35%
LTFS
28
Ladenburg Thalmann Financial Services
Florida
$11K – – –
Simplex Trading
29
Simplex Trading
Illinois
$10K -$12.7K -2,664 -55%
Group One Trading
30
Group One Trading
Illinois
$10K – – –
TRCT
31
Tower Research Capital (TRC)
New York
$6K -$1.42K -297 -20%
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$2K +$836 +175 +146%
AG
33
Advisor Group
Arizona
$1K – – –
SPIA
34
Steward Partners Investment Advisory
New York
$1K – – –
Goldman Sachs
35
Goldman Sachs
New York
– -$337K -69,567 Closed
LAM
36
Lingohr Asset Management
Germany
– -$301K -62,100 Closed
AR
37
Advisory Research
Illinois
– -$191K -39,545 Closed
Jane Street
38
Jane Street
New York
– -$134K -27,612 Closed
Two Sigma Investments
39
Two Sigma Investments
New York
– -$124K -25,631 Closed
CCIA
40
Campbell & Co Investment Adviser
Maryland
– -$86K -17,699 Closed
HF
41
HRT Financial
New York
– -$71K -14,706 Closed
Barclays
42
Barclays
United Kingdom
– -$22K -4,488 Closed
AIC
43
Ameritas Investment Company
Nebraska
– -$19K -4,024 Closed
QT
44
Quantamental Technologies
New York
– -$3K -700 Closed
JP Morgan Chase
45
JP Morgan Chase
New York
– -$1K -211 Closed
1
2

CO Hedge Fund Activity: Q4 2019 in Review

35 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q4 2019, worth a combined $96.3M — down 2.8% from $99.1M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of CO and 2 opened new positions — a net loss of 9 holders — while 12 trimmed existing stakes and 9 added.

The largest buyer was Renaissance Technologies, adding an estimated $470K. The largest seller was Jayhawk Capital Management, cutting an estimated $3.71M.

  • 35 institutional investors held Global Cord Blood Corporation (CO) as of Q4 2019, down from 44 in Q3 2019.
  • Funds reported $96.3M of Global Cord Blood Corporation stock for Q4 2019, down 2.8% quarter-over-quarter.
  • 2 funds opened new Global Cord Blood Corporation positions in Q4 2019 and 11 closed out, a net change of -9 holders.
  • The largest Global Cord Blood Corporation buyer in Q4 2019 was Renaissance Technologies, an estimated $470K added.
  • The largest Global Cord Blood Corporation seller in Q4 2019 was Jayhawk Capital Management, an estimated $3.71M sold.

Based on aggregated 13F filings for Q4 2019.